- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 471/12 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups in which the condensed system contains three hetero rings
Patent holdings for IPC class C07D 471/12
Total number of patents in this class: 182
10-year publication summary
|
18
|
13
|
8
|
5
|
9
|
6
|
12
|
9
|
12
|
10
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Janssen Pharmaceutica N.V. | 3394 |
6 |
| LG Chem, Ltd. | 17635 |
4 |
| Merck Patent GmbH | 5815 |
4 |
| ChemoCentryx, Inc. | 386 |
4 |
| Senhwa Biosciences, Inc. | 38 |
4 |
| Bristol-myers Squibb Company | 4880 |
3 |
| BASF SE | 20940 |
3 |
| Takeda Pharmaceutical Company Limited | 2708 |
3 |
| Oncoceutics, Inc. | 29 |
3 |
| Owens Corning Intellectual Capital, LLC | 1632 |
3 |
| Tel Hashomer Medical Research Infrastructure and Services Ltd. | 330 |
3 |
| Neuron23, Inc. | 25 |
3 |
| Insilico Medicine IP Limited | 128 |
3 |
| Acerand Therapeutics (Hong Kong) Limited | 11 |
3 |
| Novartis AG | 10744 |
2 |
| Syngenta Crop Protection AG | 6074 |
2 |
| Abbvie Inc. | 1800 |
2 |
| BeiGene, Ltd. | 369 |
2 |
| Chimerix, Inc. | 89 |
2 |
| Deciphera Pharmaceuticals, LLC | 224 |
2 |
| Other owners | 121 |